Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.530
-0.110 (-3.02%)
At close: Jun 16, 2026, 4:00 PM EDT
3.510
-0.020 (-0.57%)
After-hours: Jun 16, 2026, 4:10 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $233.24 million as of June 16, 2026. Its market cap has increased by 137.45% in one year.
Market Cap
233.24M
Enterprise Value
162.33M
1-Year Change
137.45%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $233.24M, a decrease of -71.00%. That is a compound annual growth rate of -20.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 231.91M | 160.35% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 239.43M |
| Sol-Gel Technologies | 238.67M |
| Orchestra BioMed Holdings | 238.33M |
| Fulcrum Therapeutics | 236.55M |
| Foghorn Therapeutics | 235.44M |
| Invivyd | 235.36M |
| InflaRx | 234.20M |
| Cellectis | 233.50M |